Thus, CD4 effector and regulatory subsets are variably affected in STAT1 GOF patients, however it remains unclear if this variability reflects specific STAT1 GOF mutation impacts and/or environmental influences such as infections or immunosuppressive treatments. The gene discussed is CD4; the disease is infection.